{"id":"W2915544780","doi":"10.3747/co.26.4116","title":"Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Centre Hospitalier de l’Université de Montréal; Alberta Cancer Foundation; McGill University Health Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital; University of Manitoba; CancerCare Manitoba; University of Ottawa","funders":"Pfizer Canada; Bristol-Myers Squibb Canada; EMD Serono; Siemens Healthineers; AstraZeneca Canada; Varian Medical Systems; Sanofi; Amgen; Pfizer; Celgene; Health Research; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Merck Canada; Accuray","keywords":"Medicine; Clinical trial; Clinical Practice; Best practice; Medical physics; MEDLINE; Intensive care medicine; Consensus conference; Lung cancer; Quality of life (healthcare); Family medicine; Oncology; Pathology; Nursing; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006814201,0.0002106679,0.0004228562,0.0002248175,0.0001031757,0.0000221497,0.00007103828,0.0001062925,0.000390356],"category_scores_gemma":[0.00001369214,0.0001737715,0.00006341987,0.0001932266,0.0001014423,0.00003357527,0.00003634299,0.0002293282,0.00008556863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008003017,"about_ca_system_score_gemma":0.002220533,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008142763,"about_ca_topic_score_gemma":0.01018119,"domain_scores_codex":[0.9987329,0.00003969743,0.0002435052,0.0003872853,0.0001210994,0.000475574],"domain_scores_gemma":[0.9988719,0.00007302422,0.0001366527,0.0002335715,0.0001802284,0.0005046261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007698745,0.000450522,0.8994727,0.0006505264,0.0004268335,0.0001922559,0.001366518,0.000020972,0.0002758455,0.000214152,0.008104224,0.08874853],"study_design_scores_gemma":[0.03243306,0.002867169,0.5025558,0.001955937,0.005913138,0.0007995397,0.003592671,0.006295094,0.00159094,0.0002589425,0.4403713,0.001366396],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9653183,0.01907924,0.00001025949,0.002631634,0.001384874,0.001397676,0.00009535972,0.00003462518,0.01004808],"genre_scores_gemma":[0.9951552,0.00114355,0.0008224877,0.0005563067,0.0001527448,0.0003490449,0.00008710584,0.00003334694,0.001700261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4322671,"threshold_uncertainty_score":0.9984621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0325985276429622,"score_gpt":0.403185643526607,"score_spread":0.3705871158836448,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}